Diagnosis and treatment of acute promyelocytic leukemia.
Acute promyelocytic leukemia (APL), characterized by a translocation between the promyelocytic leukemia gene (PML) on chromosome 15 and the retinoic acid receptor-alpha (RARalpha) gene on chromosome 17, has become a model for targeted treatment of cancer. Advances in our understanding of the fundamental biology of this disease have led to the development of tools for diagnosis, monitoring of minimal residual disease, and detection of early relapse. Differentiation therapy with all-trans retinoic acid in combination with chemotherapy has significantly improved survival in patients with APL. Moreover, arsenic trioxide, which induces differentiation and apoptosis of APL cells, has become standard treatment for relapsed disease, and its role in the treatment of newly diagnosed APL is under active investigation. The lessons learned from APL have broad applications to other forms of leukemia and to cancer in general, whereby molecularly targeted therapy is directed to specifically defined subgroups.
Jurcic
Joseph G
JG
Leukemia Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. jurcicj@mskcc.org
Soignet
Steven L
SL
Maslak
And Peter G
AP
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D014178:Translocation, Genetic
D000970:Antineoplastic Agents
Blood. 1992 Nov 1;80(9):2176-81
1421389
Blood. 1996 Feb 1;87(3):882-6
8562957
N Engl J Med. 1999 Apr 1;340(13):994-1004
10099141
Blood. 1980 Feb;55(2):253-9
6928105
Blood. 1994 Dec 1;84(11):3843-9
7949141
Blood. 1997 Aug 1;90(3):1321-5
9242568
Haematologica. 2007 Mar;92(3):315-22
17339180
Blood. 1996 Aug 1;88(3):1052-61
8704214
Blood. 2002 Dec 15;100(13):4298-302
12393590
J Clin Oncol. 2001 Sep 15;19(18):3852-60
11559723
Nat Genet. 1997 Sep;17 (1):109-13
9288109
Leukemia. 2006 Aug;20(8):1393-9
16728984
Blood. 2001 Nov 1;98(9):2651-6
11675334
Blood. 2002 Jun 1;99(11):4222-4
12010830
N Engl J Med. 1991 May 16;324(20):1385-93
1850498
Blood. 1997 May 1;89(9):3345-53
9129041
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10173-8
10954752
Lancet. 1992 Dec 12;340(8833):1437-8
1360562
Blood. 2000 Aug 15;96(4):1287-96
10942370
Nature. 1997 May 1;387(6628):43-8
9139820
J Exp Med. 2006 Apr 17;203(4):821-8
16549595
Blood. 1990 Nov 1;76(9):1704-9
2224119
J Clin Invest. 1993 May;91(5):2260-7
8387545
Hum Mol Genet. 1999 Sep;8(9):1741-9
10441338
J Clin Oncol. 1997 May;15(5):1786-95
9164186
Blood. 2004 Feb 15;103(4):1237-43
14576047
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35
15044693
Blood. 1988 Aug;72(2):567-72
3165295
Blood. 1999 Aug 15;94(4):1192-200
10438706
Blood. 2006 May 1;107(9):3469-73
16373661
J Clin Oncol. 2006 Dec 20;24(36):5703-10
17116939
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2694-8
1372989
Blood. 1997 Aug 1;90(3):1014-21
9242531
Crit Rev Oncol Hematol. 2001 Apr;38(1):37-45
11255080
N Engl J Med. 1998 Nov 5;339(19):1341-8
9801394
J Clin Oncol. 1995 May;13(5):1238-41
7738627
Oncologist. 2003;8(2):132-40
12697938
Blood. 2000 Aug 15;96(4):1247-53
10942364
J Clin Oncol. 2005 Jan 1;23(1):120-6
15534358
Leuk Lymphoma. 2006 Jun;47(6):1062-8
16840198
J Clin Oncol. 2000 Mar;18(6):1295-300
10715300
Leukemia. 2007 Mar;21(3):446-52
17205057
J Exp Med. 2001 Feb 19;193(4):521-29
11181703
Leukemia. 2006 Jan;20(1):35-41
16307026
Blood. 2000 Aug 15;96(4):1297-308
10942371
J Natl Cancer Inst. 1990 Dec 19;82(24):1932-3
2174466
Leukemia. 1995 Jan;9(1):19-24
7531260